<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117674">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01918969</url>
  </required_header>
  <id_info>
    <org_study_id>13/408</org_study_id>
    <nct_id>NCT01918969</nct_id>
  </id_info>
  <brief_title>Reference Values of Circulating Endothelial Progenitor Cells</brief_title>
  <acronym>ANOPEC2</acronym>
  <official_title>Determination of Reference Values of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in a Blood Donnor Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Jean Minjoz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Jean Minjoz</source>
  <oversight_info>
    <authority>France: Health agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- have been
      shown to be inversely correlated to aortic aneurysm size. However reference values have not
      yet been determined. This study is aimed to determine reference values of CD34+144+CD14- et
      CD34+VEGF-R2+CD14-  in healthy men and women blood donors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At the time of blood donation, 10mL of blood will be used to calculate the concentration of
      circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- , and the
      ratio of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- / all
      circulating endothelial progenitor cells in order to determine reference values.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Concentration of circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14-</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ratio of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- / all circulating endothelial progenitor cells</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Blood donors</arm_group_label>
    <description>Blood donors with no exclusion criteria i.e with a very low probability to have an aortic aneurysm</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy blood donors
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Blood donors

        Exclusion Criteria:

          -  age over 65

          -  Arterial hypertension (treated or not)

          -  Vascular disease

          -  smoker or former smoker who stopped smoking for less than a year
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Perrotti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Franche-Comte; France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pascal Morel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Etablissement Français du Sang</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Siamak Davani, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Franche-Comte. france</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sidney Chocron, MD, PhD</last_name>
    <phone>+33381533121</phone>
    <email>sidney.chocron@univ-fcomte.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sidney Chocron, MD,PhD</last_name>
    <phone>+33381533121</phone>
    <email>sidney.chocron@univ-fcomte.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sidney Chocron, MD, PhD</last_name>
      <phone>+33381533121</phone>
      <email>sidney.chocron@univ-fcomte.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Parietti E, Pallandre JR, Deschaseaux F, Aupècle B, Durst C, Kantelip JP, Chocron S, Davani S. Presence of circulating endothelial progenitor cells and levels of stromal-derived factor-1α are associated with ascending aorta aneurysm size. Eur J Cardiothorac Surg. 2011 Jul;40(1):e6-12. doi: 10.1016/j.ejcts.2011.02.065. Epub 2011 Apr 9.</citation>
    <PMID>21481600</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 7, 2013</lastchanged_date>
  <firstreceived_date>August 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital Jean Minjoz</investigator_affiliation>
    <investigator_full_name>Prof. Sidney Chocron</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Endothelial progenitor cells</keyword>
  <keyword>Healthy blood donors</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
